# OnCo record adc-cdmo-manufacturing (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/adc-cdmo-manufacturing/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "adc-cdmo-manufacturing" ;
  schema:name "ADC bioconjugation manufacturing (CDMOs)"@en ;
  schema:description "ADC bioconjugation manufacturing joins a payload so toxic it needs the top containment class (OEB 5) to an antibody, then checks drug-to-antibody ratio and free payload. Capacity sits with a handful of contractors such as Lonza, WuXi XDC and Samsung Biologics, so long queues and China-based exposure shape who can develop ADCs."@en ;
  schema:url <https://onco.cc/technologies/adc-cdmo-manufacturing/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://www.ecfr.gov/current/title-21/chapter-I/subchapter-C/part-211> ;
  onco:status "established" ;
  onco:tag "supporting" ;
  onco:sections <https://onco.cc/fronts/adcs/> ;
  onco:technologies <https://onco.cc/technologies/adc/>, <https://onco.cc/technologies/site-specific-conjugation/> ;
  onco:companies <https://onco.cc/companies/lonza/>, <https://onco.cc/companies/wuxi-xdc/>, <https://onco.cc/companies/samsung-biologics/>, <https://onco.cc/companies/piramal-pharma-solutions/>, <https://onco.cc/companies/abzena/>, <https://onco.cc/companies/synaffix/> .